Cohen & Co Q3 Revenue Falls 61% as SPAC Marks Bite

Cohen & Company Inc. (NYSE American: COHN) reported third quarter 2026 revenue of $32.4 million on 12 November 2026, down from $69.5 million in the prior quarter and $84.2 million a year earlier, after $17.6 million of mark-to-market losses on financial instruments its investment bank received as deal consideration. Net income attributable to the company was $6.7 million, or $0.12 per fully diluted share, while adjusted pre-tax income fell to $648,000. The board declared a quarterly dividend of $0.25 per share.

Context — Why Cohen & Company's Q3 Revenue Collapse Matters Now

Cohen & Company's investment banking and new issue line produced $12.7 million in the third quarter, down $41.3 million from the second quarter and $55.9 million from the year-earlier period. The company said the swing was driven by $17.6 million of mark-to-market losses on consideration it received for services, against $26.0 million of mark-to-market gains in the prior quarter. That is a $43.6 million reversal on a single line item, and it explains most of the quarter-over-quarter revenue decline.

This is the structural feature of Cohen & Company's model. Its full-service boutique investment bank, Cohen & Company Capital Markets, takes equity stakes in the SPACs it underwrites and advises. Those stakes are marked to market each quarter, so the revenue line inherits the volatility of the de-SPAC market rather than the steadier fee economics of a traditional advisory shop.

Management framed the quarter around production rather than the mark. Daniel G. Cohen, named Chief Executive Officer in a separate announcement, said the firm underwrote six SPAC IPOs and one closed-end fund raising $1.8 billion for clients, and advised on eight de-SPAC transactions. He called CCM a leading SPAC advisor on Wall Street.

The firm's mortgage-linked gestation repo book, which finances mortgage assets before securitisation, reached an all-time high of $4.5 billion during the quarter. That is the part of the balance sheet that does not reprice with SPAC sentiment, and it grew while the investment banking line contracted.

Broader market conditions are not cited in the report as a cause. The company attributed the mark to "the environment in our businesses," without quantifying which assets moved. Investors looking at the fazen.markets equities coverage will recognise the pattern: advisory revenue tied to SPAC equity is marked through the income statement, not held at cost.

Data — What Cohen & Company's Q3 Numbers Show

Total revenue fell from $84.2 million in the third quarter of 2025 to $32.4 million this quarter, a decline of 61.5%. Against the second quarter of 2026, revenue fell 53.3%.

Metric	Q3 2026	Q2 2026	Q3 2025
Total revenue	$32.4M	$69.5M	$84.2M
Investment banking and new issue	$12.7M	$54.1M	$68.6M
Net trading	$12.5M	$13.9M	$13.6M
Operating income	$2.6M	$12.4M	$21.8M
Adjusted pre-tax income	$0.6M	$10.1M	$16.4M
Fully diluted EPS	$0.12	$0.94	$2.58

Net trading revenue of $12.5 million was down $1.4 million from the prior quarter and $1.1 million from the prior year quarter, with lower revenue from the SPAC equity, corporate, agency and structured notes desks partly offset by the mortgage group.

Asset management revenue was $1.7 million, down $0.2 million sequentially and $0.3 million year over year, on roughly $1.3 billion of assets under management.

Principal transactions and other revenue swung to positive $5.5 million from negative $0.3 million in the prior quarter, driven by mark-to-market gains on the company's position in Silvia, Inc. (Nasdaq: SVIA).

Compensation and benefits expense fell $27.0 million sequentially to $21.1 million, tracking the revenue decline because pay is largely incentive-based. Headcount rose to 135 from 129 at June 30 and 124 a year earlier. The company reported a $6.3 million income tax benefit, including a $6.5 million deferred tax benefit from reducing a valuation allowance against carryforward tax assets. Total equity stood at $119.6 million at September 30, up from $103.1 million at December 31, 2025.

Analysis — What the SPAC Mark Means for COHN and Peers

The clean read on this quarter is that Cohen & Company's earnings power now depends on two things that move independently. The first is deal flow, which the company says stayed strong. The second is the market value of the equity it accepts as payment, which fell hard.

That second factor is why adjusted pre-tax income of $648,000 sits so far below net income of $6.7 million. The tax benefit and the allocation of losses to non-controlling interests do the heavy lifting on the GAAP bottom line, while the operating result is close to breakeven.

The limitation in this quarter's numbers is disclosure. The company did not name the specific instruments behind the $17.6 million mark, so an outside reader cannot tell whether the loss came from a handful of de-SPAC positions or a broad repricing. It also did not give a breakdown of the $1.8 billion raised across the six SPAC IPOs and one closed-end fund.

Positioning matters here. Cohen & Company's own shareholders sit behind a structure where a large share of economics flows to holders of Operating LLC units exchangeable into COHN shares. Fully diluted shares outstanding were 6.4 million, against 2.7 million basic shares, which is why diluted EPS of $0.12 diverges so sharply from basic EPS of $2.49. Any investor comparing COHN to a conventional boutique bank is comparing different capital structures.

The nine-month picture is less severe than the quarter. Revenue for the first nine months was $159.8 million against $172.8 million a year earlier, and fully diluted net income per share was $1.47 year to date, which the CEO cited as evidence of earnings potential. The concentration risk remains: when SPAC equity marks turn, the revenue line turns with them.

Outlook — What to Watch for Cohen & Company

The company said it is focused on consistent production through the end of the year and positioning to enter 2027 with a strong pipeline, without giving numeric guidance. It also said the board will evaluate the dividend policy each quarter and that future decisions may be affected by operating results and capital needs.

Three things to track. First, whether the gestation repo book holds near the $4.5 billion level or continues to grow, since that revenue is not tied to SPAC marks. Second, whether the investment banking line recovers in the fourth quarter or posts a second consecutive mark-driven shortfall. Third, the size of any further valuation allowance adjustment, which the company flagged as potentially material in either direction.

The dividend of $0.25 per share is payable on 14 December 2026 to stockholders of record as of 30 November 2026. At the current run rate, that payout is not covered by this quarter's adjusted pre-tax income.

Frequently Asked Questions

Why did Cohen & Company's revenue fall so much in Q3 2026?

Investment banking and new issue revenue dropped to $12.7 million from $54.1 million in the prior quarter. The company said $17.6 million of mark-to-market losses on financial instruments it received as consideration for services drove the decline, compared with $26.0 million of mark-to-market gains in the second quarter. Total revenue fell to $32.4 million from $69.5 million sequentially.

Is Cohen & Company's dividend safe after this quarter?

The board declared $0.25 per share, payable 14 December 2026 to holders of record on 30 November 2026. The company said it will evaluate the dividend policy each quarter and that future decisions may be affected by operating results and capital needs. Adjusted pre-tax income of $648,000 in the quarter was below the implied cost of the payout.